Danielle Rogers-Candee
Psychiatric/Mental Health · Louisville, KYNPI 1265849145
Payments from drug & device makers
Across 264 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$566
- AbbVie$525
- Corium, LLC$500
- Otsuka America Pharmaceutical, Inc.$424
- Supernus Pharmaceuticals, Inc.$339
- Bausch Health US, LLC$333
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,646100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 19 | $566 |
| AbbVie | 45 | $525 |
| Corium, LLC | 29 | $500 |
| Otsuka America Pharmaceutical, Inc. | 18 | $424 |
| Supernus Pharmaceuticals, Inc. | 33 | $339 |
| Bausch Health US, LLC | 20 | $333 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $317 |
| Alkermes, Inc. | 15 | $317 |
| Vanda Pharmaceuticals Inc. | 7 | $195 |
| Noven Therapeutics, LLC | 10 | $182 |
| Johnson & Johnson | 7 | $130 |
| Axsome Therapeutics, Inc. | 6 | $123 |
| Tris Pharma Inc | 6 | $121 |
| Ironshore Pharmaceuticals Inc. | 6 | $103 |
| Almatica Pharma LLC | 4 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $78 |
| Idorsia Pharmaceuticals US Inc | 5 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $55 |
| Sunovion Pharmaceuticals Inc. | 3 | $51 |
| Neurocrine Biosciences, Inc. | 3 | $44 |
| Neos Therapeutics, LP | 3 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Alfasigma USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$115
- Azstarys$106
How this compares
$4,651 in reported general payments places this provider in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 31 | $47,405 |
| TrintellixVortioxetine Hydrobromide | 52 | $33,142 |
| VraylarCariprazine Hcl | 12 | $17,034 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,093 |
| Lisdexamfetamine Dimesylate | 15 | $4,001 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 52 | $1,722 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 65 | $1,698 |
| Vilazodone Hcl | 31 | $1,555 |
| Tranylcypromine Sulfate | 13 | $1,179 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $1,127 |
| Lamotrigine | 99 | $903 |
| Prazosin Hcl | 22 | $785 |
| Quetiapine Fumarate | 29 | $594 |
| Mirtazapine | 23 | $588 |
| Bupropion XlBupropion Hcl | 40 | $436 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $424 | $47,40531 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $55 | $37,23663 claims |
| AbbVieVraylar | $525 | $17,03412 claims |
| Almatica Pharma LLCSertraline Hcl | $79 | $5817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Louisville
- Denise de AngelisLouisville$384K
- Mark BushLouisville$52K
- Harold O'BrienLouisville$28K
- Shane WattsLouisville$13K
- Clinton RayhillLouisville$9K
- Michelle LoseLouisville$7K
- Ryan HopsonLouisville$7K
- Kimberly ViltLouisville$7K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.